just spitballingI wonder wether they might consider selling off Nyngan to finance the CMR/HPA projects. We would still have the two remaining scandium deposits and all the patents and a revenue source. If the price is right maybe a small dividend for us shareholders with no dilution. Or am I just running out of ideas.